Delaisse JM, Andersen TL, Kristensen HB, Jensen PR, Andreasen CM, Søe K. Re-thinking the bone remodeling cycle mechanism and the origin of bone loss. Bone [Internet]. Elsevier; 2020;141:115628. Available from: https://doi.org/10.1016/j.bone.2020.115628.
Isales CM, Seeman E. Modeling IB. Menopause and age - related bone loss. 2019;155–161.
Compston JE, McClung MR, Leslie WD. Osteoporosis. Lancet. 2019;393:364–76.
CAS PubMed Article Google Scholar
Kanis JA, Norton N, Harvey NC, Jacobson T, Johansson H, Lorentzon M, et al. SCOPE 2021: a new scorecard for osteoporosis in Europe. Arch Osteoporos. 2021;16.
Office of Disease Prevention and Health Promotion, Office of the Assistant Secretary for Health, Office of the Secretary USD of H and HS. Osteoporosis Workgroup. US Department of Health and Human Services [Internet]. 2020. Available from: https://health.gov/healthypeople/about/workgroups/osteoporosis-workgroup#:~:text=In the United States%2C an,at increased risk for osteoporosis.
Schmidt CW. A measure of strength: developmental PFAS exposures and bone mineral content in adolescence. Environ Health Perspect. 2021;129:1–2.
Lewiecki EM, Ortendahl JD, Vanderpuye-Orgle J, Grauer A, Arellano J, Lemay J, Harmon AL, Broder MS, Singer AJ. Healthcare policy changes in osteoporosis can improve outcomes and reduce costs in the United States. JBMR Plus. 2019;3:1–7.
Madsen CM, Jantzen C, Norring-Agerskov D, Vojdeman FJ, Abrahamsen B, Lauritzen JB, Jørgensen HL. Excess mortality following hip fracture in patients with diabetes according to age: a nationwide population-based cohort study of 154,047 hip fracture patients. Age Ageing. 2019;48:559–63.
Guzon-Illescas O, Perez Fernandez E, Crespí Villarias N, Quirós Donate FJ, Peña M, Alonso-Blas C, et al. Mortality after osteoporotic hip fracture: incidence, trends, and associated factors. J Orthop Surg Res. 2019;14:1–9.
Bliuc D, Center JR. Determinants of mortality risk following osteoporotic fractures. Curr Opin Rheumatol United States. 2016;28:413–9.
Cauley JA, Thompson DE, Ensrud KC, Scott JC, Black D. Risk of mortality following clinical fractures [Internet]. Osteoporos. Int. London : Springer-Verlag London Limited ; 2000. p. 556–561. Available from: https://go.exlibris.link/hdQ3bNBT
Cummings SR, Lui LY, Eastell R, Allen IE. Association between drug treatments for patients with osteoporosis and overall mortality rates: a meta-analysis. JAMA Intern Med. 2019;179:1491–500.
PubMed PubMed Central Article Google Scholar
Alarkawi D, Bliuc D, Tran T, Ahmed LA, Emaus N, Bjørnerem A, Jørgensen L, Christoffersen T, Eisman JA, Center JR. Impact of osteoporotic fracture type and subsequent fracture on mortality: the Tromsø Study. Osteoporos Int. 2020;31:119–30.
CAS PubMed Article Google Scholar
Zanker J, Duque G. Osteoporosis in older persons: old and new players. J Am Geriatr Soc. 2019;67:831–40.
de Vries TJ, Schoenmaker T, Hooibrink B, Leenen PJM, Everts V. Myeloid blasts are the mouse bone marrow cells prone to differentiate into osteoclasts. J Leukoc Biol. 2009;85:919–27.
PubMed Article CAS Google Scholar
Grigoriadis AE, Kennedy M, Bozec A, Brunton F, Stenbeck G, Park IH, Wagner EF, Keller GM. Directed differentiation of hematopoietic precursors and functional osteoclasts from human ES and iPS cells. Blood. 2010;115:2769–76.
CAS PubMed PubMed Central Article Google Scholar
Cairoli E, Eller-Vainicher C, Ulivieri FM, Zhukouskaya VV, Palmieri S, Morelli V, Beck-Peccoz P, Chiodini I. Factors associated with bisphosphonate treatment failure in postmenopausal women with primary osteoporosis. Osteoporos Int. 2014;25:1401–10.
CAS PubMed Article Google Scholar
Møller AMJ, Delaisse JM, Olesen JB, Bechmann T, Madsen JS, Søe K. Zoledronic acid is not equally potent on osteoclasts generated from different individuals. JBMR Plus. 2020;4:1–13. This paper studies the varying effect of zoledronic acid on osteoclasts obtained from different individuals in vitro.
McDonald MM, Khoo WH, Ng PY, Xiao Y, Zamerli J, Thatcher P, et al. Osteoclasts recycle via osteomorphs during RANKL-stimulated bone resorption. Cell. 2021;184:1330-1347.e13. This paper studies the recycling of osteoclasts via daughter cells known as osteomorphs. Osteomorphs may be involved in the regulation of bone resorption.
Madel MB, Ibáñez L, Ciucci T, Halper J, Rouleau M, Boutin A, et al. Dissecting the phenotypic and functional heterogeneity of mouse inflammatory osteoclasts by the expression of cx3cr1. Elife. 2020;9:1–22. This paper provides new insights into inflammatory osteoclast heterogeneity.
Smieszek A, Marcinkowska K, Pielok A, Sikora M. The role of miR-21 in osteoblasts – osteoclasts. Cells. 2020;9:1–21.
Møller AMJ, Delaissé JM, Olesen JB, Madsen JS, Canto LM, Bechmann T, et al. Aging and menopause reprogram osteoclast precursors for aggressive bone resorption. Bone Res [Internet]. Springer US; 2020;8. Available from: https://doi.org/10.1038/s41413-020-0102-7. This paper studies the effect of age and menopause on osteoclast precursors and their subsequent effect leading to aggressive bone resorption.
Yi L, Li Z, Jiang H, Cao Z, Liu J, Zhang X. Gene modification of transforming growth factor β (TGF-β) and interleukin 10 (IL-10) in suppressing Mt sonicate induced osteoclast formation and bone absorption. Med. Sci. Monit. 2018. p. 5200–7.
Jacome-Galarza CE, Percin GI, Muller JT, Mass E, Lazarov T, Eitler J, et al. Developmental origin, functional maintenance and genetic rescue of osteoclasts. Nature [Internet]. Springer US; 2019;568:541–5. Available from: https://doi.org/10.1038/s41586-019-1105-7. This paper studies the developmental origin and longevity of osteoclasts, but also looks at the mechanism behind the maintenance of bones after birth in mice.
Parfitt AM. Osteonal and hemi-osteonal remodeling: the spatial and temporal framework for signal traffic in adult human bone. J Cell Biochem. United States. 1994;55:273–86.
Baron R, Tross R, Vignery A. Evidence of sequential remodeling in rat trabecular bone: morphology, dynamic histomorphometry, and changes during skeletal maturation. Anat Rec. 1984;208:137–45.
CAS PubMed Article Google Scholar
Sambrook PN, Hughes DR, Nelson AE, Robinson BG, Mason RS. Osteocyte viability with glucocorticoid treatment: relation to histomorphometry. Ann Rheum Dis. 2003;62:1215–7.
CAS PubMed PubMed Central Article Google Scholar
Hurley MM, Lee SK, Raisz LG, Bernecker P, Lorenzo J. Basic fibroblast growth factor induces osteoclast formation in murine bone marrow cultures. Bone [Internet]. 1998;22:309–316. Available from: https://www.sciencedirect.com/science/article/pii/S8756328297002925
Yaccoby S, Wezeman MJ, Henderson A, Cottler-Fox M, Yi Q, Barlogie B, Epstein J. Cancer and the microenvironment: myeloma-osteoclast interactions as a model. Cancer Res. 2004;64:2016–23.
CAS PubMed Article Google Scholar
Rissanen JP, Suominen MI, Peng Z, Halleen JM. Secreted tartrate-resistant acid phosphatase 5b is a marker of osteoclast number in human osteoclast cultures and the rat ovariectomy model. Calcif Tissue Int. 2008;82:108–15.
CAS PubMed Article Google Scholar
Jaworski ZFG. Physiology and pathology of bone remodeling: cellular basis of bone structure in health and in osteoporosis. Orthop Clin North Am [Internet]. 1981;12:485–512. Available from: https://www.sciencedirect.com/science/article/pii/S0030589820313687
Tonna EA. H3-histidine and H3-thymidine autoradiographic studies of the possibility of osteoclast aging. Lab Invest [Internet]. 1966;15:435—448. Available from: http://europepmc.org/abstract/MED/5932609
Thul PJ, Åkesson L, Wiking M, Mahdessian D, Geladaki A, Blal HA, et al. A subcellular map of the human proteome. Science (80- ). 2017;356:eaal3321.
The Human Protein Atlas [Internet]. Available from: https://www.proteinatlas.org/ENSG00000141968-VAV1/tissue
Tissue expression of VAV1 - Summary - The Human Protein Atlas. :2–4. Available from: https://www.proteinatlas.org/ENSG00000141968-VAV1/tissue
Yahara Y, Barrientos T, Tang YJ, Puviindran V, Nadesan P, Zhang H, et al. Erythromyeloid progenitors give rise to a population of osteoclasts that contribute to bone homeostasis and repair. Nat Cell Biol [Internet]. Springer US; 2020;22:49–59. Available from: https://doi.org/10.1038/s41556-019-0437-8. This paper identifies an erythromyeloid progenitor (EMP)-derived osteoclast precursor population, which arises independently of the hematopoietic stem cell (HSC) lineage.
Flewitt* R. Conducting research with young children: some ethical considerations. Early Child Dev Care [Internet]. Routledge; 2005;175:553–65. Available from: https://doi.org/10.1080/03004430500131338.
Orcel P, Bielakoff J, De Vernejoul MC. Formation of multinucleated cells with osteoclast precursor features in human cord monocytes cultures. Anat Rec [Internet]. John Wiley & Sons, Ltd; 1990;226:1–9. Available from: https://doi.org/10.1002/ar.1092260102.
Penolazzi L, Pocaterra B, Tavanti E, Lambertini E, Vesce F, Gambari R, et al. Human osteoclasts differentiated from umbilical cord blood precursors are less prone to apoptotic stimuli than osteoclasts from peripheral blood. Apoptosis [Internet]. 2008;13:553–61. Available from: https://doi.org/10.1007/s10495-008-0188-7.
Erices A, Conget P, Minguell JJ. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol [Internet]. John Wiley & Sons, Ltd; 2000;109:235–42. Available from: https://doi.org/10.1046/j.1365-2141.2000.01986.x.
Monaco MCG, Maric D, Salvucci O, Passeri CAL, Accorsi P, Major EO, et al. Identification of circulating CD31+CD45+ cell populations with the potential to differentiate into erythroid cells. Stem Cell Res Ther [Internet]. 2021;12:236. Available from: https://doi.org/10.1186/s13287-021-02311-y.
Yang C-T, French A, Goh PA, Pagnamenta A, Mettananda S, Taylor J, et al. Human induced pluripotent stem cell derived erythroblasts can undergo definitive erythropoiesis and co-express gamma and beta globins. Br J Haematol [Internet]. John Wiley & Sons, Ltd; 2014;166:435–48. Available from: https://doi.org/10.1111/bjh.12910.
Heppe DHM, Medina-Gomez C, de Jongste JC, Raat H, Steegers EAP, Hofman A, et al. Fetal and childhood growth patterns associated with bone mass in school-age children: the Generation R Study. J Bone Miner Res [Internet]. John Wiley & Sons, Ltd; 2014;29:2584–93. Available from: https://doi.org/10.1002/jbmr.2299.
Vidulich L, Norris SA, Cameron N, Pettifor JM. Infant programming of bone size and bone mass in 10-year-old black and white South African children. Paediatr Perinat Epidemiol [Internet]. John Wiley & Sons, Ltd; 2007;21:354–62. Available from: https://doi.org/10.1111/j.1365-3016.2007.00806.x.
Balasuriya CND, Evensen KAI, Mosti MP, Brubakk A-M, Jacobsen GW, Indredavik MS, et al. Peak bone mass and bone microarchitecture in adults born with low birth weight preterm or at term: a cohort study. J Clin Endocrinol Metab [Internet]. 2017;102:2491–500. Available from: https://doi.org/10.1210/jc.2016-3827.
Laitinen J, Kiukaanniemi K, Heikkinen J, Koiranen M, Nieminen P, Sovio U, et al. Body size from birth to adulthood and bone mineral content and density at 31 years of age: results from the northern Finland 1966 birth cohort study. Osteoporos Int [Internet]. 2005;16:1417–24. Available from: https://doi.org/10.1007/s00198-005-1857-9.
Bonjour JP, Chevalley T, Ferrari S, Rizzoli R. The importance and relevance of peak bone mass in the prevalence of osteoporosis. Salud Publica Mex. 2009;51:5–17.
Marks SC, Seifert MF. The lifespan of osteoclasts: experimental studies using the giant granule cytoplasmic marker characteristic of beige mice. Bone [Internet]. 1985;6:451–5 Available from: https://www.sciencedirect.com/science/article/pii/8756328285902236.
Jaworski ZFG, Duck B, Sekaly G. Kinetics of osteoclasts and their nuclei in evolving secondary Haversian systems. J Anat. 1981;133:397–405.
CAS PubMed PubMed Central Google Scholar
Wang B, Jin H, Zhu M, Li J, Zhao L, Zhang Y, et al. Chondrocyte β-catenin signaling regulates postnatal bone remodeling through modulation of osteoclast formation in a murine model. Arthritis Rheumatol [Internet]. John Wiley & Sons, Ltd; 2014;66:107–20. Available from: https://doi.org/10.1002/art.38195.
Rauch F. The dynamics of bone structure development during pubertal growth. J Musculoskelet Neuronal Interact. 2012;12:1–6.
Suda T, Takahashi N, Martin TJ. Modulation of osteoclast differentiation. Endocr Rev [Internet]. 1992;13:66–80. Available from: https://doi.org/10.1210/edrv-13-1-66.
Mizuno H, Kikuta J, Ishii M. In vivo live imaging of bone cells. Histochem Cell Biol [Internet]. Springer Berlin Heidelberg; 2018;149:417–22. Available from: https://doi.org/10.1007/s00418-018-1638-0.
Khosla S, Hofbauer LC. Osteoporosis treatment: recent developments and ongoing challenges. Lancet Diabetes Endocrinol [Internet]. Elsevier Ltd; 2017;5:898–907. Available from: https://doi.org/10.1016/S2213-8587(17)30188-2.
Bi H, Chen X, Gao S, Yu X, Xiao J, Zhang B, Liu X, Dai M. Key triggers of osteoclast-related diseases and available strategies for targeted therapies: a review. Front Med. 2017;4:1–10.
Ishii M, Egen JG, Klauschen F, Meier-Schellersheim M, Saeki Y, Vacher J, et al. Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis. Nature. Nature Publishing Group; 2009;458:524–528.
Ishii M, Kikuta J, Shimazu Y, Meier-Schellersheim M, Germain RN. Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and bone remodeling in vivo. J Exp Med. 2010;207:2793–8.
CAS PubMed PubMed Central Article Google Scholar
Vico L, Hargens A. Skeletal changes during and after spaceflight. Nat Rev Rheumatol [Internet]. Nature Publishing Group; 2018;14:229–45. Available from: https://doi.org/10.1038/nrrheum.2018.37.
Baron R, Vignery A. Behavior of osteoclasts during a rapid change in their number induced by high doses of parathyroid hormone or calcitonin in intact rats. Metab Bone Dis Relat Res. 1981;2:339–46.
Jansen IDC, Vermeer JAF, Bloemen V, Stap J, Everts V. Osteoclast fusion and fission. Calcif Tissue Int. 2012;91:159.
CAS PubMed Central Article Google Scholar
Solari F, Domenget C, Gire V, Woods C, Lazarides E, Rousset B, Jurdic P. Multinucleated cells can continuously generate mononucleated cells in the absence of mitosis: a study of cells of the avian osteoclast lineage. J Cell Sci. 1995;108:3233–41.
CAS PubMed Article Google Scholar
Burckhardt P, Faouzi M, Buclin T, Lamy O. Fractures after denosumab discontinuation: a retrospective study of 797 cases. J Bone Miner Res. 2021;36:1717–28.
CAS PubMed Article Google Scholar
Bone HG, Bolognese MA, Yuen CK, Kendler DL, Miller PD, Yang YC, Grazette L, San Martin J, Gallagher JC. Effects of denosumab treatment and discontinuation on bone mineral density and bone turnover markers in postmenopausal women with low bone mass. J Clin Endocrinol Metab. 2011;96:972–80.
CAS PubMed Article Google Scholar
Dufrançais O, Mascarau R, Poincloux R, Maridonneau-Parini I, Raynaud-Messina B, Vérollet C. Cellular and molecular actors of myeloid cell fusion: podosomes and tunneling nanotubes call the tune. Cell Mol Life Sci [Internet]. Springer International Publishing; 2021;78:6087–104. Available from: https://doi.org/10.1007/s00018-021-03875-x.
Huynh N, Vonmoss L, Smith D, Rahman I, Felemban MF, Zuo J, et al. Characterization of regulatory extracellular vesicles from osteoclasts. J Dent Res. 2016;95:673–9.
留言 (0)